CDLX News and Press, Cardlytics Inc. From 07/12/22

Stocks lost ground on Tuesday, weighed down by concerns about upcoming inflation data and the beginning of the corporate earnings season. Continuing weakness seen the day before, the Nasdaq led the retreat with a 1% decline. ServiceNow ( NYSE: NOW ) contributed to the pessimisti...

Cardlytics ( NASDAQ: CDLX ) shares dropped over 6% on Tuesday after Craig-Hallum downgraded the stock from buy to hold. The brokerage also lowered its price target from $50 to $20, implying a 21% increase from last closing price. Craig-Hallum analyst Jason Kreyer ...

Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...

J.P. Morgan has saved some of today's biggest estimate cuts for companies competing in online advertising as it anticipates a weaker operating environment in the second half of the year and into 2023. That's part of a deep dive where the firm cut estimates and price targets on 26 co...

By partnering with banks, Cardlytics has 178M monthly active users (MAU) and access to data of 1 in 2 US purchase transactions. This is very unique. CDLX is building a true ecosystem for advertising and consumer research. It benefits every participant on the platform! CDLX can del...

ATLANTA, May 31, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc. , (NASDAQ: CDLX), a digital advertising platform, today announced it will present at the Bank of America 2022 Global Technology Conference. Chief Executive Officer and Co-Founder, Lynne Laube, will present on Tuesday, June...

ATLANTA, May 12, 2022 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today released its Q1 2022 State of Spend Report . With insight into 1 out of every 2 debit and credit card swipes in the US, Cardlytics found that overall...

Cardlytics (NASDAQ:CDLX) has announced a stock repurchase authorization to buyback $40M of its common stock. The repurchase program is expected to continue through the end of the current fiscal year unless extended or shortened by the board. Last week, the digital advertising company rep...

ATLANTA, May 10, 2022 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX) (the “Company”), a digital advertising platform, today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40.0 million of its Common Stock. “We believe...

Cardlytics (NASDAQ:CDLX) is up 6% in premarket trading, Tuesday, after the company reported solid beat on both lines in its first quarter's earnings results. Revenue of $67.9M (+27.6% Y/Y) beats by $3.24M. Non-GAAPE metric, billings increased to $98.2M (+29% Y/Y). Cardlytics MAUs were 17...